[REVISION HISTORY]
Jacob Grandison doping violation and suspension
Updated 1 time since CLSTR started tracking revisions of this situation.
What changed
2026-09-06 10:38 UTC → 2026-09-06 15:23 UTC ·
added
removed
Finnish basketball player Jacob Grandison tested positive for amphetamine during the EuroBasket tournament. Grandison 2025 tournament in Tampere. Grandison, who contributed to Finland’s victory over Serbia in the round of 16, attributed the positive result to the use of Adderall, a medication prescribed for ADHD. While the player stated he had a medical prescription and Grandison had informed the Finnish national team’s medical staff, the violation occurred because staff of his medication use, a required therapeutic use exemption (TUE) was not obtained. officially processed due to an administrative error. The Finnish Basketball Federation has accepted full responsibility for this procedural failure. As a result of the finding, result, Grandison received a three-month suspension, which suspension from FIBA-organized competitions. This suspension prevented him from competing for the French club Boulazac. Following the investigation, the Finnish Basketball Association’s head of coaching, Henrik Dettmann, took responsibility for the administrative failure to complete the exemption process. Grandison has since obtained the necessary exemption Boulazac and returned concluded in early January 2026. Grandison is expected to professional play. be eligible for FIBA competitions again starting in January 2026.
Versions
- 2026-09-06 15:23 UTC Jacob Grandison doping violation and suspension
- 2026-09-06 10:38 UTC Jacob Grandison doping violation and suspension
Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.